शनिवार, 13 अगस्त 2011

india is projected to be the third-largest pharma market






india is projected to be the third-largest pharma market (after the US and China) in terms of incremental growth. It is also evident that the sub-continent, with the highest population and robust economic growth, offers attractive return to pharma companies due to its cost effective manufacturing capabilities and branded generics nature of the market. As the domestic pharma market grows in size and diversity, there are several opportunities that will scale up to their full potential. Some of these include biologics and vaccines, consumer healthcare, patented products and hospital segment, which are at an early stage of lifecycle, but are likely to scale up with upgradation of therapies, increased penetration of multi-specialty hospitals and changes in patients preference. According to industry sources, these opportunities will collectively grow to USD 25 bn by 2020 from the current USD 5 bn.

कोई टिप्पणी नहीं:

एक टिप्पणी भेजें

LinkWithin

LinkWithin

Related Posts Plugin for WordPress, Blogger...